After donating $176 million in proceeds from his original stock options in 2023, Stéphane Bancel is taking a different path ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.

The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's ...

Get the live share price of Moderna Inc (MRNA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast pipeline. Considering the full picture, now, with the stock down 80% over ...

Nvidia (NVDA) shares recently found strong buying support at below $175. That led to an uptrend, followed by a 3.01% lift for ...

Stocks end the week little changed. Meanwhile, Rivian jumps 22%, while Nike falls.

Momentum traders who seek fast-moving stocks have three to look at. Sandisk (SNDK) gained 15.2% in the last week. It trades ...

Nasdaq Composite (IXIC), and S&P 500 Index (SPX) are all trying for a fourth-straight win today, though the outstanding GDP report dampens interest rate cut sentiment. Despite the choppiness today, ...